Markets:

Overview

News

Currencies

International

Treasuries

Mydecine Innovations Group Inc (OP:MYCOF)

0.2182 UNCHANGED

Last Price Updated: 9:30 AM EST, Dec 22, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Mydecine Innovations Group Inc

< Previous 1 2 3 4 5 6 7 Next >

Mydecine On Verge Of Finalizing Spin-Out Of Cannabis Subsidiaries, Obtains Shareholder And Court Approval ↗

September 27, 2021

Psychedelics and mycology company Mydecine Innovations Group Inc. (NEO: MYCO) (OTC:

Via Benzinga

Topics Cannabis

Which Psychedelic Stock ETF Is Right For You? ↗

September 18, 2021

This week the AdvisorShares Psychedelics ETF began trading on the NYSE Arca. Here we compare the make-up of the now 3 psychedelic stock ETFs and two tracking indexes.

Via Talk Markets

Psyched: CaamTech Raises $22M, Mydecine To Launch Smoking Cessation Trial, Michigan Bill Could Decriminalize Psychedelics ↗

September 13, 2021

Last Week In Psychedelics:

Via Benzinga

Cannabis And Psychedelic Drug Stock Performances Were Mixed Last Week ↗

September 11, 2021

The performance of the psychedelic-focused index components substantially outshone the weed stocks.

Via Talk Markets

Topics Cannabis

National Suicide Prevention Week Shines Light on Psychedelic Treatments

September 09, 2021

Via FinancialNewsMedia

Psychedelic Drug Industry Report Card For 2021 ↗

September 01, 2021

In assessing the psychedelic drug industry, a primary focus for investors is drug development.

Via Talk Markets

Magic Mushroom Drug Stock Performances YTD ↗

August 29, 2021

Of the 35 companies involved in clinical stage research of psychedelic substances, 20 are researching the benefits of psilocybin, the primary psychoactive ingredient in “magic mushrooms”.

Via Talk Markets

PharmaDrug Strikes Deal With Johns Hopkins University For A Clinical Trial Into Psychedelic DMT ↗

August 26, 2021

On Wednesday, PharmaDrug Inc. (CSE:PHRX) (OTC:

Via Benzinga

Psyched: Beckley Psytech Raises $80M, Diamond Therapeutics To Study Psilocybin Microdosing, Mydecine and Johns Hopkins Partner Up ↗

August 23, 2021

Beckley Psytech Closes $80 Million Series B Beckley Psytech announced

Via Benzinga

Mydecine Innovations Inks Deal With Johns Hopkins University To Undertake Psychedelics Research Into Smoking Cessation ↗

August 18, 2021

Mydecine Innovations Group (NEO: MYCO) (OTC:MYCOF) has signe...

Via Benzinga

Which Psychedelic Drug Stock Category Outperformed Last Week ↗

August 10, 2021

Which has performed best YTD, the Pure-Play Marijuana Drug Stocks Index or the Pure-Play Psychedelic Compounds-Based Drug Stocks Index?

Via Talk Markets

Topics Cannabis

Which Psychedelic Drug Has The Most Commercial Potential? ↗

August 10, 2021

As the Mental Health Crisis has become a mental health pandemic, clinical research on psychedelic drugs is showing that these substances are the best – and only – option to address this crisis.

Via Talk Markets

Marijuana Vs. Mushroom Psychedelic Drug Stocks: A Current & YTD Performance Comparison ↗

July 24, 2021

We identify the performance of the top 8 clinical-stage psychedelic companies in each of the marijuana and mushroom drug stock categories during the past 5 trading days, July to date, and YTD.

Via Talk Markets

Topics Cannabis

Psychedelics Gain More Traction as New Research Aims to Address Chronic Pain and Mental Illness

July 21, 2021

Via FinancialNewsMedia

Topics Law Enforcement

Telehealth Boom Is Driving this Mental Health Company’s Progress

July 13, 2021

Via FinancialNewsMedia

How The Pot And Psychedelic Stocks Performed Last Week And YTD ↗

July 13, 2021

Approximately 100 clinical-stage marijuana and mushroom/ketamine psychedelic drug stocks now trade on the various North American stock exchanges.

Via Talk Markets

Topics Cannabis

How To Invest In "Magic Mushrooms" (Psychedelics) ↗

July 09, 2021

A look at psychedelics as stock market investment opportunities and identifying alternative strategies on how to invest.

Via Talk Markets

Psychedelics Research FYI: Every Clinical Trial Underway Right Now Involving Public And Private Companies ↗

July 07, 2021

This article was made possible thanks to invaluable research by Michael Haichin and Josh Hardman from Ps...

Via Benzinga

The 6 Leading Psychedelic Stocks In Drug R&D ↗

July 07, 2021

Drug R&D in the emerging psychedelic drug industry continues to advance. Share prices continue to lag. Here's a comparison of the strengths and weaknesses of six of the leaders in psychedelic drug R&D...

Via Talk Markets

Psyched: GH Research Debuts on Nasdaq, Compass Reaches Psilocybin Research Milestone, Maxim Gives BUY Rating to 10 Psychedelics Companies ↗

July 02, 2021

Irish 5-MeO-DMT Company GH Research Debuts On Nasdaq GH Research, a Dublin-based company studying the potential o...

Via Benzinga

Maxim Group Gives Buy Rating To 10 Psychedelic Stocks: Compass, MindMed, Cybin, Field Trip And More ↗

June 30, 2021

Institutional analysts are taking a liking to the industry ...

Via Benzinga

Psyched: Atai Life Sciences Hits Nasdaq, Canada To Fund Ketamine Trials, Mydecine Launches AI Drug-Discovery Platform ↗

June 21, 2021

Atai Life Sciences (NASDAQ: ATAI) made its highly-anticipated Nasdaq...

Via Benzinga

Topics Artificial Intelligence

Mydecine Identifies 4 Psychedelic-Related Drugs to Tackle the Mental Health Crisis ↗

June 17, 2021

Photo by Christopher Ott on

Via Benzinga

Mydecine Innovations Group Launches AI-Assisted Drug Discovery Program ↗

June 16, 2021

Mydecine Innovations Group (NEO: MYCO) (OTC:MYCOF), a biotech company in the ...

Via Benzinga

Psychedelic Drug Stocks Index -21% In May; Now -25% YTD ↗

May 31, 2021

46 psychedelic drug stocks now trade on the various North American stock exchanges and the 11 with the largest market capitalizations make up the Pure-Play Psychedelic Drug Stocks Index.

Via Talk Markets

Psyched: Nasdaq Gets Its Third Psychedelics Company, Mynd Goes Public, Delic Buys New Research Facility ↗

May 28, 2021

The Nasdaq welcomed its third psychedelics company this week, with

Via Benzinga

Mydecine Reports First Quarter 2021 Financial Results and Provides Business Update

May 20, 2021

Via Get News

Mydecine To Spin-Out Its U.S. Cannabis Assets By Mid July ↗

May 19, 2021

Psychedelics and mycology company, Mydecine Innovations Group Inc. (NEO: MYCO) (OTC:

Via Benzinga

Topics Cannabis

The Next Psychedelic Stock To Uplist On The Nasdaq? ↗

May 04, 2021

As MindMed Inc makes its long-awaited move to the Nasdaq, the obvious question is: who's next?

Via Talk Markets

Mydecine Posts $26.9M Net Loss For 2020: What's Ahead For Psychedelic Stock ↗

May 04, 2021

Denver-based Mydecine Innovations Group (NEO: MYCO) (OTC:MYCOF

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.